Acurx Pharmaceuticals LLC (ACXP) — Defensive Interval Ratio

Latest as of June 2026: 12 days

Acurx Pharmaceuticals LLC (ACXP) has a Defensive Interval Ratio of 12 days as of June 2026. Defensive assets of $95.31K (cash $-, short-term investments $-, receivables $95.31K) cover 12 days of daily cash needs of $7.76K/day.

Defensive Interval Ratio

12 days
Days of operational coverage

Defensive Assets

$95.31K
Cash + ST Investments + Receivables

Daily Cash Need

$7.76K
Current Liabilities ÷ 365

Current Liabilities

$2.83 Million
USD

Acurx Pharmaceuticals LLC Defensive Interval Ratio (2023–2025)

This chart shows how Acurx Pharmaceuticals LLC's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of June 2026, the ratio stands at 12 days, meaning defensive assets of $95.31K can fund 12 days of operations without new revenue. For the complete balance sheet picture, see balance sheet size of Acurx Pharmaceuticals LLC.

Annual Defensive Interval Ratio for Acurx Pharmaceuticals LLC (2023–2025)

The table below presents the year-by-year Defensive Interval Ratio for Acurx Pharmaceuticals LLC from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See ACXP working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 7 days $48.42K $6.63K/day $- $- ▲ +2 days
2024 6 days $51.13K $8.88K/day $- $- ▼ -10 days
2023 15 days $129.16K $8.34K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)